Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rami Y Haddad

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Disease-A-Month : DM|October 5, 2014
Renal amyloidosisSammer Jazbeh, Albara Said, Rami Y Haddad, et al.
Disease-A-Month : DM|October 6, 2014
Sickle cell nephropathyRichard Gargiulo, Mauna Pandya, Amber Seba, et al.
Disease-A-Month : DM|October 8, 2014
Multiple myelomaGautam Raju Mehta, Faten Suhail, Rami Y Haddad, et al.
Disease-A-Month : DM|February 4, 2018
Sickle cell disease; An overview of the disease and its systemic effectsSahar Alrayyes, Danny Baghdan, Rami Y Haddad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2020
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline UpdateNasser H Hanna, Bryan J Schneider, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2021
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline UpdateNasser H Hanna, Andrew G Robinson, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2022
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living GuidelineNavneet Singh, Sarah Temin, Sherman Baker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2022
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living GuidelineNavneet Singh, Sarah Temin, Sherman Baker, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Disease-A-Month : DM|October 5, 2014
Renal amyloidosisSammer Jazbeh, Albara Said, Rami Y Haddad, et al.
Disease-A-Month : DM|October 6, 2014
Sickle cell nephropathyRichard Gargiulo, Mauna Pandya, Amber Seba, et al.
Disease-A-Month : DM|October 8, 2014
Multiple myelomaGautam Raju Mehta, Faten Suhail, Rami Y Haddad, et al.
Disease-A-Month : DM|February 4, 2018
Sickle cell disease; An overview of the disease and its systemic effectsSahar Alrayyes, Danny Baghdan, Rami Y Haddad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2020
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline UpdateNasser H Hanna, Bryan J Schneider, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2021
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline UpdateNasser H Hanna, Andrew G Robinson, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2022
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living GuidelineNavneet Singh, Sarah Temin, Sherman Baker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2022
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living GuidelineNavneet Singh, Sarah Temin, Sherman Baker, et al.
Pageof 2